ArticleCureus2025
Management of Extensive Hepatic Metastases From Adenoid Cystic Carcinoma of the Parotid Gland by Embolization and Hemi-Hepatectomy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Resection of Liver Metastasis from Lacrimal Gland Adenoid Cystic Carcinoma: A Case Report and Review of the Literature.Surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenoid cystic carcinoma (ACC) is a rare malignancy of the salivary glands characterized by slow growth, perineural invasion, and a predilection for distant metastasis, primarily to the lungs and bones. Liver metastasis from ACC is uncommon and poses significant diagnostic and therapeutic challenges. This report presents a case of mixed type of ACC (predominantly cribriform and tubular architecture with a solid component of 20%) originating in the parotid gland with multiple liver metastases from a tertiary center in India. A 32-year-old woman initially underwent a total conservative parotidectomy with facial nerve preservation and adjuvant radiotherapy for ACC of the right parotid gland in 2017. Immunohistochemistry was positive for CD117, S100, and smooth muscle actin (SMA). Following a recurrence of metastatic neck lymph node involvement in 2020, she underwent right modified radical neck dissection and additional radiation therapy. In 2024, surveillance imaging revealed liver lesions, confirmed as ACC metastases by biopsy with immunohistochemistry. Due to inadequate hepatic reserve for a right hemi-hepatectomy, a right portal vein embolization was performed to induce hypertrophy of the left liver. Subsequent right hemi-hepatectomy with segment II metastatectomy achieved an R0 resection, and the patient experienced an uneventful recovery. She remained disease-free six months postoperatively. ACC accounts for 1%-2% of all head and neck cancers and exhibits distinct clinical and pathological features. Its treatment is centered on surgical resection with adjuvant radiotherapy, although the efficacy of chemotherapy is limited. Liver metastasis, though rare, can be managed with surgical intervention in selected cases, potentially improving survival outcomes. This case underscores the importance of long-term follow-up for ACC patients due to the risk of delayed distant metastases. It also highlights the role of multidisciplinary management and individualized treatment strategies in achieving optimal outcomes in rare and complex clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.